Could a Mail-In HPV test replace the pap smear?
NCT ID NCT07575217
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether mailing HPV self-sampling kits to people who are overdue for cervical cancer screening makes it easier for them to get tested. Researchers will enroll 200 women, transgender men, and nonbinary individuals aged 30-75 in New Jersey. Participants can choose to use the mailed kit or go to a clinic for a standard Pap smear. The goal is to see if this approach improves screening rates and is acceptable to users.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HPV self-sampling kit
What this could lead to
If successful, this could make cervical cancer screening more accessible and convenient for people who miss regular checkups.
What could go wrong
This is a small, early-stage study (200 participants) focused on feasibility, not on detecting cancer directly. The self-sampling method may not be as accurate as clinic-based tests.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER SCREENING are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••